Predictors of Recurrence in CRSwNP

Hear Drs. Katie Buchheit and Martin Wagenmann discuss the rates of recurrence following endoscopic sinus surgery for patients with CRSwNP and different methods of predicting which patients will respond well to surgery and which patients would fare better with a different approach. ADVENT is a medical education non-promotional program for healthcare professionals organized by Sanofi and Regeneron. This podcast is intended for healthcare professionals only. Disclaimer: This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits Speaker disclosures:  Dr. Katie Buchheit: K. Buchheit has served on scientific advisory boards and/or received honoraria from AstraZeneca, Regeneron, Sanofi-Genzyme, Eli Lilly and GlaxoSmithKline, receives royalties from UpToDate, and receives research funding from NIH/NIAID and Regeneron. Dr. Martin Wagenmann: Fees for lectures and / or participation in scientific advisory boards: Advanz Pharma, ALK-Abelló, Allergopharma, AstraZeneca, Celltrion, CSL Behring, GSK, HAL Allergie, med update, MSD, NeilMed, Regeneron, Sanofi, Stallergenes, Streamed Up; Grants (to institution): ALK-Abelló, AstraZeneca, EU, GSK, Novartis, Regeneron, Sanofi, Takeda © 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2506006 - 1.0 - 1/2026 MAT-US-2600233 v1.0 - P Exp Date: 01/07/2028